Cognition Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 37
Rang # Quantité totale PI 38 090
Note d'activité PI 2,2/5.0    23
Rang # Activité PI 35 068
Symbole boursier CGTX (nasdaq)
ISIN US19243B1026
Capitalisation 17.60M  (USD)

Brevets

Marques

17 0
4 0
16 0
0
 
Dernier brevet 2024 - Compositions for treating neurod...
Premier brevet 2007 - Inhibitors of cognitive decline

Derniers inventions, produits et services

2024 Invention Isoindoline compositions and methods for treating neurodegenerative disease. Presented herein are...
Invention Compositions for treating neurodegenerative diseases. The present disclosure relates to novel co...
2023 Invention Isoindoline compositions and methods for treating neurodegenerative disease. The present inventio...
Invention Isoindoline compositions and methods for treating neurodegenerative disease. Isoindoline sigma-2...
2022 Invention Compositions and methods for treating neurologic diseases. The present disclosure relates to met...
Invention Compositions and methods for treating neurologic diseases. The present disclosure relates to meth...
2021 Invention Compositions for treating dry age-related macular degeneration (amd). The present disclosure rel...
Invention Compositions for treating dry age-related macular degeneration (amd). The present disclosure rela...
Invention Coated particles for turf infill. The present embodiments are directed, in part, to coated partic...
Invention Compositions for treating neurodegenerative diseases. The present disclosure relates to novel com...
Invention Method of decreasing amyloid beta monomer levels in patients with cognitive decline. The present...
Invention Method of decreasing amyloid beta monomer levels in patients with cognitive decline. The present ...
2020 Invention Isoindoline compositions and methods for treating neurodegenerative disease. Isoindoline sigma-2 ...
2018 Invention Isoindoline compositions and methods for treating neurodegenerative disease. The present inventi...
2017 Invention Compositions and methods for treating neurodegenerative disease. This invention relates to the u...
2016 Invention Isolated compounds from turmeric oil and methods of use. Compounds that are central nervous syst...
Invention Inhibitors of cognitive decline. Compounds that are central nervous system drug candidates for t...
2015 Invention Inhibitors of cognitive decline. Compounds that are central nervous system drug candidates for th...
Invention Isoindoline compositions and methods for treating neurodegenerative disease. The present applicat...
2012 Invention Compositions and methods for treating neurodegenerative disease. This invention relates to novel...
Invention Compositions and methods for treating neurodegenerative disease. This invention relates to novel ...
Invention Compositions and methods for treating neurodegenerative disease. This invention relates to the us...
Invention Isolated compounds from turmeric oil and methods of use. Compounds that are central nervous syste...
2011 Invention Methods of identifying agents effective to treat cognitive decline and diseases associated therew...
Invention Compositions and method for determining the efficacy of amyloidosis treatments. Embodiments desc...